机构:[1]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.内科系统科技平台老年医学科神经变性病教育部重点实验室首都医科大学宣武医院[2]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, 100069, China.[3]Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, 100069, China.[4]Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, B4 7ET, UK.[5]Department of Clinical Neurosciences, Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.[6]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.内科系统科技平台老年医学科神经变性病教育部重点实验室首都医科大学宣武医院[7]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, 100069, China.[8]Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, 100069, China.
This work was supported by Stem Cell and Translation National Key Project
(2016YFA0101403), National Natural Science Foundation of China (82171250
and 81973351), Beijing Municipal Natural Science Foundation (5142005),
Beijing Talents Foundation (2017000021223TD03), Support Project of Highlevel
Teachers in Beijing Municipal Universities in the Period of 13th Five–year
Plan (CIT and TCD20180333), Beijing Municipal Health Commission Fund
(PXM2020_026283_000005), Beijing One Hundred, Thousand, and Ten Thousand
Talents Fund (2018A03), Royal Society-Newton Advanced Fellowship
(NA150482), and National Science Foundation for Young Scientists of China
(31900740).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|2 区细胞与组织工程2 区细胞生物学2 区医学:研究与实验
最新[2023]版:
大类|2 区医学
小类|2 区细胞与组织工程2 区细胞生物学2 区医学:研究与实验
JCR分区:
出版当年[2022]版:
Q1CELL & TISSUE ENGINEERINGQ1CELL BIOLOGYQ1MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1CELL & TISSUE ENGINEERINGQ1CELL BIOLOGYQ1MEDICINE, RESEARCH & EXPERIMENTAL
第一作者机构:[1]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.[2]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, 100069, China.[3]Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, 100069, China.
通讯作者:
通讯机构:[6]Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.[7]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing, 100069, China.[8]Center of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, 100069, China.
推荐引用方式(GB/T 7714):
Li Qian,Liu Sumei,Zheng Tianqi,et al.Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury[J].STEM CELL RESEARCH & THERAPY.2024,15(1):35.doi:10.1186/s13287-024-03651-1.
APA:
Li Qian,Liu Sumei,Zheng Tianqi,Li Mo,Qi Boling...&Chen Zhiguo.(2024).Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury.STEM CELL RESEARCH & THERAPY,15,(1)
MLA:
Li Qian,et al."Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury".STEM CELL RESEARCH & THERAPY 15..1(2024):35